Table 1 Summary of serum and CSF studies obtained on present hospitalization

 Cholesterol, Total

179

< 200 mg/dL

 Triglycerides

253

< 200 mg/dL

 LDL

114

< 130 mg/dL

 Lipoprotein a

133

< 75 nmol/L

 Beta-2-glycoprotein Antibody, IgG

< 10.0

< 20.1 CU

 Beta-2-glycoprotein Antibody, IgM

< 5.0

< 20.1 CU

 Protein C, Activity

99

76–146%

 Anti-Cardiolipin Antibody, IgG

15.8

< 20.1 CU

 Anti-Cardiolipin Antibody, IgM

< 10.0

< 20.1 CU

 Lupus Anticoagulant by HEXA

Neg

Neg

 RVVT Seconds

30.9

29.0–44.0 s

 WBC

1

< 6 x10E6/L

 RBC

44

0 x10E6/L

 Glucose

76

40–70 mg/dL

 Protein

13

15–50 mg/dL

 IgG Index

0.6

0.3–0.6 Ratio

 Serum glucose

164

< 200

 Rapid HSV-1 PCR

Neg

Neg

 Rapid HSV-2 PCR

Neg

Neg

 VZV PCR

Neg

Neg

 VZV IgM

0.03

< 0.9

 Hemoglobin A1c

6.4

4.3–5.6%

 TSH

0.64

0.45–4.12 mlU/L

 Free T4

13

10–18 pmol/L

 CRP

5.4 - > 36.9

< 6.3

 ESR

> 100

0–15 mm/h

 Anti-Nuclear Antibodies

< 40

< 40

 Anti Proteinase 3 Ab

< 10.0

< 20.0 CU

 Anti Myeloperoxidase

< 10.0

< 20.0 CU

 GAD-65 Autoantibodies

< 1.0

< 1.0 U/mL

 Insulin Autoantibody

< 0.4

< 0.4 U/mL

 Islet Cell Antigen 512 Antibody

< 0.8

< 0.8 U/mL

 Rheumatoid Factor, serum

< 40

< 40 IU/mL

 Complement C3, serum

101

71–159 mg/dL

 Complement C4, serum

26.4

13–30 mg/dL

 Cryoglobulin

< 0.12

< 0.12 g/L

 Heterophile Agglutination

Neg

Neg

 Hepatitis B sAb

< 5

mIU/mL

 Hepatitis B cAb

Neg

Neg

 Hepatitis B sAg

Neg

Neg

 Hepatitis C Antibody

Neg

Neg

 HIV Ag/Ab

Neg

Neg